RK
Ravi Kumar Seshadri
About Ravi Kumar Seshadri
Data last updated:
Ravi Kumar Seshadri is a Director at Aspeya India Private Limited (since 2022) and Managing Director at Fertin India Private Limited (since 2013). The companies operate in Pharma and Food and Beverages. The 2 current companies with reported revenue have a combined latest revenue of ₹76.13 Cr; the largest is Aspeya India Private Limited at ₹44.93 Cr (FY 2025). Earlier, Ravi Kumar Seshadri was a Managing Director at Fertin Pharma Research And Development India Private Limited (from 2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 02 Aug 2022 | 2022 | ₹44.93 Cr (FY 2025) | Active | |
| Managing Director | 10 Jun 2013 | 2013 | ₹31.20 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 05 Sep 2011 | 2011 | ₹9.72 Cr (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Ravi Kumar Seshadri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ankur Modi | 09620104 | Aspeya India Private Limited | Director |
| Michael Henrik Thomsen | 08022446 | Aspeya India Private Limited , Fertin India Private Limited | Director |
| Sagar Krishnarao Boke | 09809125 | Aspeya India Private Limited | Director |
| Lene Frederiksen Lind | 09441666 | Fertin India Private Limited | Director |
| Priyanka Pradip Padhye | Fertin India Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ravi Kumar Seshadri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ravi Kumar Seshadri
Ravi Kumar Seshadri currently holds 2 directorships: Aspeya India Private Limited (Director, since 02 Aug 2022, revenue ₹44.93 Cr (FY 2025)); Fertin India Private Limited (Managing Director, since 10 Jun 2013, revenue ₹31.20 Cr (FY 2025)).
Ravi Kumar Seshadri was first appointed on 05 Sep 2011 as Managing Director at Fertin Pharma Research And Development India Private Limited. The most recent appointment on record is 02 Aug 2022 at Aspeya India Private Limited.
The 2 current companies of Ravi Kumar Seshadri that report revenue have a combined latest revenue of ₹76.13 Cr: Aspeya India Private Limited ₹44.93 Cr (FY 2025); Fertin India Private Limited ₹31.20 Cr (FY 2025).
Ravi Kumar Seshadri held 1 earlier board appointment: Fertin Pharma Research And Development India Private Limited (Managing Director, from 05 Sep 2011).
The current boards of Ravi Kumar Seshadri's companies include Ankur Modi (Aspeya India Private Limited), Michael Henrik Thomsen (Aspeya India Private Limited), Sagar Krishnarao Boke (Aspeya India Private Limited), Lene Frederiksen Lind (Fertin India Private Limited), Priyanka Pradip Padhye (Fertin India Private Limited).